113,66 €
126,29 €
-10% with code: EXTRA
Handbook of Her2-Targeted Agents in Breast Cancer
Handbook of Her2-Targeted Agents in Breast Cancer
113,66
126,29 €
  • We will send in 10–14 business days.
This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
126.29
  • Publisher:
  • Year: 2016
  • Pages: 110
  • ISBN-10: 331928214X
  • ISBN-13: 9783319282145
  • Format: 12.7 x 20.3 x 0.7 cm, minkšti viršeliai
  • Language: English
  • SAVE -10% with code: EXTRA

Handbook of Her2-Targeted Agents in Breast Cancer (e-book) (used book) | bookbook.eu

Reviews

Description

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

EXTRA 10 % discount with code: EXTRA

113,66
126,29 €
We will send in 10–14 business days.

The promotion ends in 22d.16:27:26

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,26 Book Euros!?
  • Author: Ricardo H Alvarez
  • Publisher:
  • Year: 2016
  • Pages: 110
  • ISBN-10: 331928214X
  • ISBN-13: 9783319282145
  • Format: 12.7 x 20.3 x 0.7 cm, minkšti viršeliai
  • Language: English English

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)